We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

High Levels of Nosocomial Infection Found in Pediatric ICUs

By HospiMedica International staff writers
Posted on 14 Feb 2017
Image: Potential sources of nosocomial infections in the ICU (Photo courtesy of Wikipedia).
Image: Potential sources of nosocomial infections in the ICU (Photo courtesy of Wikipedia).
One in six children in pediatric intensive care units (pICU), and one in ten babies in neonatal intensive care units (nICU) develop a hospital-acquired infection (HAI), according to a new study.

Researchers at the European Centre for Disease Control, University of Geneva Hospitals, St George's University of London, and other institutions conducted a study that analyzed pediatric data from point-prevalence surveys conducted in 1,149 hospitals throughout the European Union, Iceland, Norway, and Croatia between May 2011 and November 2012. In all, data were collected by locally trained healthcare workers for 17,273 children and adolescents from 29 countries.

An analysis of he data revealed 770 HAIs reported in 726 children and adolescents, corresponding to a prevalence of 4.2%. Bloodstream infections were the most common type of infection (45% of all infections), followed by lower respiratory tract infections (22%), gastrointestinal infections (8%), eye, ear, nose, and throat infections (7%), urinary tract infections (5%), and surgical-site infections (4%). The prevalence of infections was highest in pICU (15.5%) and nICU (10.7%) wards. The study was published on January 12, 2017, in The Lancet Infectious Diseases.

“This is the largest multi-national study describing healthcare-associated infections in children so far, providing detailed information about the prevalence and distribution of these infections in this specific population,” stated the ECDC. “A second point prevalence survey is ongoing in Europe, including improvements to address some of the limitations found during the development of the study, and its results will be published by the European Centre for Disease Prevention and Control after 2017.”

HAIs are defined as those occurring 48 hours after admission, within three days of discharge, or within 30 days of surgery. They can be caused by organisms lurking on the bodies or clothing of healthcare workers and on hospital surfaces such as doorknobs, curtains, and furniture. Resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), erythromycin-resistant Enterococcus, and carbapenem-resistant Enterobacteriaceae acerbate the problem.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Digital Color Doppler Ultrasound System
MS22Plus

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more